{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:58:46Z","timestamp":1784224726982,"version":"3.55.0"},"reference-count":28,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00944","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T03:42:58Z","timestamp":1502250178000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Late-Onset Non-HLH Presentations of Growth Arrest, Inflammatory Arachnoiditis, and Severe Infectious Mononucleosis, in Siblings with Hypomorphic Defects in UNC13D"],"prefix":"10.3389","volume":"8","author":[{"given":"Paul Edgar","family":"Gray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bella","family":"Shadur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Thia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Trapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin Philip","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilia","family":"Voskoboinik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,8,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jaci.2015.06.048","article-title":"Genetic predisposition to hemophagocytic lymphohistiocytosis: report on 500 patients from the Italian registry","volume":"137","author":"Cetica","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev-med-041610-134208","article-title":"Familial and acquired hemophagocytic lymphohistiocytosis","volume":"63","author":"Janka","year":"2012","journal-title":"Annu Rev Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1182\/blood-2010-05-282541","article-title":"Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2","volume":"116","author":"Meeths","year":"2010","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fimmu.2013.00441","article-title":"Perforinopathy: a spectrum of human immune disease caused by defective perforin delivery or function","volume":"4","author":"Voskoboinik","year":"2013","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/cdd.2009.212","article-title":"Perforin deficiency and susceptibility to cancer","volume":"17","author":"Brennan","year":"2010","journal-title":"Cell Death Differ"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.3324\/haematol.2010.029389","article-title":"Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases","volume":"95","author":"Rohr","year":"2010","journal-title":"Haematologica"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1182\/blood-2010-08-300046","article-title":"Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis","volume":"117","author":"Sumegi","year":"2011","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4103\/1817-1745.106477","article-title":"Spinal cord involvement in a child with familial hemophagocytic lymphohistiocytosis","volume":"7","author":"Gokce","year":"2012","journal-title":"J Pediatr Neurosci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.bbmt.2013.09.001","article-title":"An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis","volume":"19","author":"Marsh","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"B10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/icb.2015.1","article-title":"Heterozygosity for the common perforin mutation, A91V, impairs the cytotoxicity of primary Natural Killer cells from healthy individuals","volume":"93","author":"House","year":"2015","journal-title":"Immunol Cell Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1002\/pbc.25646","article-title":"Spectrum of atypical clinical presentations in patients with biallelic PRF1 missense mutations","volume":"62","author":"Tesi","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/jmg.2007.054288","article-title":"Spectrum, and clinical and functional implications of UNC13D mutations in familial haemophagocytic lymphohistiocytosis","volume":"45","author":"Rudd","year":"2008","journal-title":"J Med Genet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/nri1983","article-title":"Perforin-mediated target-cell death and immune homeostasis","volume":"6","author":"Voskoboinik","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1182\/blood-2004-09-3590","article-title":"Severe and progressive encephalitis as a presenting manifestation of a novel missense perforin mutation and impaired cytolytic activity","volume":"105","author":"Feldmann","year":"2005","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/art.22442","article-title":"Primary necrotizing lymphocytic central nervous system vasculitis due to perforin deficiency in a four-year-old girl","volume":"56","author":"Moshous","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00381-008-0744-z","article-title":"Diagnostic challenges in a child with familial hemophagocytic lymphohistiocytosis type 3 (FHLH3) presenting with fulminant neurological disease","volume":"25","author":"Weisfeld-Adams","year":"2009","journal-title":"Childs Nerv Syst"},{"key":"B17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s10875-015-0194-9","article-title":"Cerebral vasculitis in X-linked lymphoproliferative disease cured by matched unrelated cord blood transplant","volume":"35","author":"Gray","year":"2015","journal-title":"J Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ajh.20261","article-title":"X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis","volume":"78","author":"Kanegane","year":"2005","journal-title":"Am J Hematol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1365-2559.1994.tb00005.x","article-title":"Familial haemophagocytic lymphohistiocytosis. A report of three cases with unusual lung involvement","volume":"25","author":"Popper","year":"1994","journal-title":"Histopathology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1203\/00006450-199510000-00001","article-title":"X-linked lymphoproliferative disease: twenty-five years after the discovery","volume":"38","author":"Seemayer","year":"1995","journal-title":"Pediatr Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/rheumatology\/kep418","article-title":"Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis","volume":"49","author":"Vastert","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3324\/haematol.2014.121608","article-title":"The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis","volume":"100","author":"Bode","year":"2015","journal-title":"Haematologica"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1182\/blood-2014-05-573105","article-title":"Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis","volume":"124","author":"Zhang","year":"2014","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1182\/blood-2015-12-688960","article-title":"Polygenic mutations in the cytotoxicity pathway increase susceptibility to develop HLH immunopathology in mice","volume":"127","author":"Sepulveda","year":"2016","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/bjh.14147","article-title":"Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities","volume":"174","author":"Brisse","year":"2016","journal-title":"Br J Haematol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.clim.2008.04.013","article-title":"What does it take to call it a pathogenic mutation?","volume":"128","author":"Fleisher","year":"2008","journal-title":"Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1182\/blood-2015-12-684498","article-title":"The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis","volume":"127","author":"Hartz","year":"2016","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e536","DOI":"10.1016\/S2352-3026(15)00223-9","article-title":"Cancer risk in relatives of patients with a primary disorder of lymphocyte cytotoxicity: a retrospective cohort study","volume":"2","author":"Lofstedt","year":"2015","journal-title":"Lancet Haematol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00944\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T03:43:01Z","timestamp":1502250181000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00944\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,9]]},"references-count":28,"alternative-id":["10.3389\/fimmu.2017.00944"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00944","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,9]]},"article-number":"944"}}